Risk and Safety of Probiotics
Open accessThe DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.
Abstract
Probiotics have been used safely for years. Safety outcomes are inconsistently reported in published clinical trials. In 2011, a report released by the Agency for Healthcare Research and Quality concluded that, although the existing probiotic clinical trials reveal no evidence of increased risk, "the current literature is not well equipped to answer questions on the safety of probiotics in intervention studies with confidence." Critics point out that the preponderance of evidence, including the long history of safe probiotic use as well as data from clinical trials, and animal and in vitro studies all support the assumption that probiotics are generally safe for most populations. Theoretical risks have been described in case reports, clinical trial results and experimental models, include systemic infections, deleterious metabolic activities, excessive immune stimulation in susceptible individuals, gene transfer and gastrointestinal side effects. More research is needed to properly describe the incidence and severity of adverse events related to probiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although probiotics are widely used and generally considered safe for healthy individuals, accumulating evidence indicates that their safety profile varies significantly depending on the strain, dose, host, and context, with rare but clinically significant adverse events reported in vulnerable populations.”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Vulnerable populations (newborns, immunocompromised individuals, and critically ill individuals) are at greater risk; therefore, assessing regulatory compliance requires a combination of biochemical and metabolomic studies, whole genome sequencing for virulence, antibiotic resistance genes and motility mapping [63,66,87].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, in the same year, Doron et al. (2015) conducted an analysis based solely on traditional literature review methods based on the results of 622 probiotic safety studies [63].”
From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with established guidance, probiotic safety is linked to intended use, strain identity, and historical evidence of safe exposure, and is distinct from classical pathogenic risk assessment.20-22”
From Safety and efficacy concerns in Indian probiotics: Insights from whole-genome sequencing and in vitro assessment (2026) · cites this paper as [22]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The presence of such ARGs and VFs may have clinical relevance, particularly in immunocompromised individuals or those with disrupted gut barriers, where opportunities for opportunistic infection or horizontal gene transfer may be increased.22,29-35”
From Safety and efficacy concerns in Indian probiotics: Insights from whole-genome sequencing and in vitro assessment (2026) · cites this paper as [22]
Experimental — accuracy not yet measured
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial
Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., & Isolauri, E. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04259-8 · Cited by 2,432 · cited 1×
“Pregnant women [19–21] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii None”
BackgroundBesselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60207-x · Cited by 1,367
Probiotics in the management of atopic eczema
Isolauri, E., Arvola, T., SÜtas, Y., Moilanen, E., & Salminen, S. (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00943.x · Cited by 974 · cited 1×
“Infants [15–18] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii, Bb12, L reuteri One mechanical choking episode reported”
BackgroundProbiotics: A novel approach in the management of food allergy
Majamaa, H., & Isolauri, E. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70093-9 · Cited by 918 · cited 1×
“Infants [15–18] LGG, LC705, Bb99, and Propionibacterium freudenreichii spp shermanii, Bb12, L reuteri One mechanical choking episode reported”
BackgroundProbiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Goldenberg, J. Z., Ma, S. S., Saxton, J. D., Martzen, M. R., Vandvik, P. O., Thorlund, K., Guyatt, G. H., & Johnston, B. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006095.pub3 · Cited by 741
Lactobacillus Sepsis Associated With Probiotic Therapy
Land, M. H., Rouster-Stevens, K., Woods, C. R., Cannon, M. L., Cnota, J., & Shetty, A. K. (2005) · Pediatrics · doi:10.1542/peds.2004-2137 · Cited by 599 · cited 1×
“Nine cases of overt sepsis have been reported [57–63], asso-”
BackgroundKhalesi, S., Sun, J., Buys, N., & Jayasinghe, R. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03469 · Cited by 516
Rayes, N., Seehofer, D., Theruvath, T., Schiller, R. A., Langrehr, J. M., Jonas, S., Bengmark, S., & Neuhaus, P. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00649.x · Cited by 478 · cited 2×
“Immunocompromised [12–14] Pediacoccus pentosaceus, Leuconostoc mesenteroides, Lactobacillus paracasei subspecies paracasei F19, Lactobacillus plantarum, LGG, L.”
BackgroundRayes, N., Seehofer, D., Hansen, S., Boucsein, K., M??ller, A. R., Serke, S., Bengmark, S., & Neuhaus, P. (2002) · Transplantation · doi:10.1097/00007890-200207150-00021 · Cited by 476 · cited 2×
“Immunocompromised [12–14] Pediacoccus pentosaceus, Leuconostoc mesenteroides, Lactobacillus paracasei subspecies paracasei F19, Lactobacillus plantarum, LGG, L.”
Background
Research works printed but not linked: 3
- Kukkonen, 2008, Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial, Pediatrics, 122, 8, 10.1542/peds.2007-1192 · DOI · Paper page
- Trautmann, 2008, Fungemia due to Saccharomyces cerevisiae var. boulardii, Chemother J, 17, 57
- Lestin, 2003, Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities, Dtsch Med Wochenschr, 128, 2531
Cited by
Items 601–700 of 1,000
Negi, A., Pasam, T., & Dandekar, M. P. (2022) · Research Square · doi:10.21203/rs.3.rs-2029234/v1 · Cited by 5
THE ROLE OF GUT MICROBIOTA IN THE DEVELOPMENT OF OBESITY
Воловникова, В. А., Kotrova, A., Ivanova, K. A., Ермоленко, Е. И., & Shishkin, A. N. (2019) · Juvenis scientia · doi:10.32415/jscientia.2019.06.01 · Cited by 5
Zhao, J., Liu, H., & Badehnoosh, B. (2025) · Antonie van Leeuwenhoek · doi:10.1007/s10482-025-02162-0 · Cited by 5
“…is a serious concern for immunocompromised individuals (e.g., organ transplant recipients, those on chemotherapy), the critically ill, and patients with severe gut barrier dysfunction (Kumar et al. 2024b; Schupack et al. 2022; Nieves et al. 2025; Kothari et al. 2019; Doron and Snydman 2015).”
Probiotics in the prevention and control of foodborne diseases in humans
Hassan, A. A., Sayed-ElAhl, R. M. H., Hamaky, A. M. E., Oraby, N. H., & Barakat, M. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823733-5.00008-8 · Cited by 5
Effects of synbiotics on the gut microbiota, blood and rearing parameters of chickens
Śliżewska, K., Markowiak‐Kopeć, P., Żbikowski, A., & Szeleszczuk, P. (2019) · FEMS Microbiology Letters · doi:10.1093/femsle/fnz116s · Cited by 5
Microbiota and its therapeutic implications in reproductive health and diseases
Singh, P., & Srivastava, R. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99336-4.00003-3 · Cited by 5
Functionality and Safety of Probiotics
Seo, Y., Yoon, Y., & Kim, S. (2019) · Journal of Dairy Science and Biotechnology · doi:10.22424/jmsb.2019.37.2.94 · Cited by 5
Bezpieczeństwo stosowania probiotyków przez ludzi
Sionek, B., & Kołożyn‐Krajewska, D. (2019) · Zywnosc-nauka Technologia Jakosc · doi:10.15193/zntj/2019/120/293 · Cited by 5
Young, W., Jester, T., Stoll, M. L., & Ízcue, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-79026-8_19 · Cited by 5
Brăgaru, M. A., Kraft, A., Moldovan, C., Moldovan, A.-D., Adam, R., Cochior, D., Luca, A., NICA-BADEA, D., Chirsanov-Capanu, S.-E., & Rusu, E. E. (2026) · Nutrients · doi:10.3390/nu18060984 · Cited by 5
“Rigorous patient selection, adherence to clinically validated strains, and monitoring in high-risk contexts are key safeguards [78].”
Wu, W.-H., Lee, C., Chen, Y.-C., Chiang, M., & Chiu, C. (2023) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2023.05.013 · Cited by 5
Case Series of Bacteremia Associated with Probiotic Use in Children after Cardiac Surgery, China
Wang, X., Li, S., 霍达, Li, C., Zhang, Q., & Wang, X. (2026) · Emerging infectious diseases · doi:10.3201/eid3201.250298 · Cited by 5
Prebiotic Effects of Chinese Herbal Polysaccharides on NAFLD Amelioration: The Preclinical Progress
Jiang, L.-Y., Kan, Y.-N., Yu, Z., Jian, B., Yao, S., Lv, L.-Y., & Liu, J. (2022) · Natural Product Communications · doi:10.1177/1934578x221124751 · Cited by 5
“potentially pathogenic bacteria.(94,95) By directly detecting the distribution of intestinal flora, Zmora et al found that standard probiotic bacteria could not successfully colonize the digestive tracts of two-thirds of subjects, termed “resisters” by the authors.”
BackgroundEmerging Trends in Skin Anti-Photoaging by Lactic Acid Bacteria: A Focus on Postbiotics
Jin, X., Nguyen, T. T. M., Yi, E.-J., Zheng, Q., Park, S.-J., Yi, G.-S., Yang, S.-J., Kim, M., & Yi, T. (2024) · Chemistry · doi:10.3390/chemistry6060090 · Cited by 5
Saccharomyces cerevisiae fungemias: how heterogenous is their management?
Diop, C. S., Descy, J., Sacheli, R., Meex, C., Sinpetrean, A., Layios, N., & Hayette, M. (2024) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2024.116343 · Cited by 5
Bjerring, P. N., Morgan, M. Y., Vilstrup, H., Nielsen, S. M., Christensen, R., & Gluud, L. L. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013241 · Cited by 5
Memariani, H., Memariani, M., Eskandari, S. E., Ghasemian, A., & Nematollahi, A. N. (2025) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2025.102840 · Cited by 5
Determination of antibiotic resistance of lactic acid bacteria isolates of probiotic foods
Turhan, E. Ü., & Erginkaya, Z. (2016) · Pamukkale University Journal of Engineering Sciences · doi:10.5505/pajes.2016.87369 · Cited by 5
Reassessing the death risk related to probiotics in critically ill patients
Maraolo, A. E. (2016) · Critical Care · doi:10.1186/s13054-016-1565-1 · Cited by 5
“In spite of their clinical use for a long time, the exact role of probiotics in many therapeutic settings is still not clear, and safety issues in special populations (pregnant women, immunosuppressed, severe underlying diseases) are the main matter of concern [4].”
BackgroundVaccines as therapies for food allergies
Landers, J. J., & O’Konek, J. J. (2021) · Advances in pharmacology · doi:10.1016/bs.apha.2021.01.003 · Cited by 5
Postbiotic-Mediated Obesity Reduction via Bioactive Peptide ETLVK and Gut Microbiota in HFD Mice
Da, J.-Y., Wang, C., Feng, X., Li, H.-L., Zhong, F., & Luo, X. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c07319 · Cited by 5
Kaltsas, A., Pournaras, S., Giannakodimos, I., Markou, E., Stavropoulos, M., Papaharitou, S., Dimitriadis, F., Zachariou, A., Sofikitis, N., & Chrisofos, M. (2026) · Journal of Personalized Medicine · doi:10.3390/jpm16020099 · Cited by 5
“Therapy should also be stopped if clinically relevant adverse effects develop or tolerability is poor, recognizing that reported events in adults are usually mild and gastrointestinal, while rare invasive infections have been described mainly in high-risk settings [121].”
Barakat, H., & Alfheeaid, H. A. (2026) · Antioxidants · doi:10.3390/antiox15060727 · Cited by 5
“…, Saccharomyces boulardii ) have been documented, predominantly in critically ill, immunocompromised, or catheterized patients, and matched case–control data indicate markedly increased odds of probiotic exposure among patients with invasive infections by typical probiotic species [201,203,204].”
Liu, P., Li, Q., Chen, Y., Yue, X., Yang, F., & Yang, Y. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.176316 · Cited by 5
Alharbi, S., & Obaid, N. A. (2025) · International Journal of General Medicine · doi:10.2147/ijgm.s498171 · Cited by 5
“The pharmacists completely agreed that probiotics improve digestive disorders, while experienced gastroenterologists (46 and older) partially disagreed that probiotics can improve digestive functions.”
InfluentialAntibiotics, the microbiome and gastrointestinal cancers: A causal interference?
Ramai, D., Salati, M., Pomati, G., Amoroso, C., Facciorusso, A., Botticelli, A., & Ghidini, M. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102315 · Cited by 4
Yu, Y., Jin, F., Wang, L., Cheng, J., & Pan, S. (2025) · Veterinary Sciences · doi:10.3390/vetsci12070642 · Cited by 4
“Theoret-ically, there could be four kinds of side effects: systemic infections, deleterious metabolic activities, excessive immune stimulation in susceptible individuals, and gene transfer [87].”
Ennab, W., Tharwat, M., Mousa, A. A., LIU, H. J., Al-Rabadi, G. J., Baiome, B. A., Alshanbari, F. A., & Cai, D. (2026) · Frontiers in Veterinary Science · doi:10.3389/fvets.2026.1852579 · Cited by 4
Won, S., Jeong, Y., Kim, J.-E., Kim, J., Song, H. S., Bae, H.-H., Kwak, M., Kim, D., Sung, M., & Kwak, S. (2024) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2411.11069 · Cited by 4
Probiotics: beneficial microbes for health and the food industry
Pal, A. D., & Pal, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13932-1.00026-x · Cited by 4
Personalised medicine based on host genetics and microbiota applied to colorectal cancer
González, A., Badiola, I., Fullaondo, A., Rodríguez, J., & Odriozola, A. (2024) · Advances in genetics · doi:10.1016/bs.adgen.2024.08.004 · Cited by 4
Probiotics and Prebiotics in Healthy Ageing
Kadam, A., Kadam, D., Tungare, K., & Shah, H. S. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-83017-5_5 · Cited by 4
Gut Microbiota and Inflammatory Bowel Disease
Vakili, B., Shoaei, P., Esfandiari, Z., & Siadat, S. D. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105842 · Cited by 4
DO PROBIOTICS HAVE A FUTURE IN NEONATOLOGY?
Знаменська, Т. К., & Vorobiova, O. V. (2021) · Neonatology surgery and perinatal medicine · doi:10.24061/2413-4260.xi.3.41.2021.7 · Cited by 4
Industrial Requirements and Other Techno-functional Traits of Probiotics
Rajivgandhi, G. N., Vimala, R. T. V., Ramachandran, G., & Manoharan, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822909-5.00030-7 · Cited by 4
Updated Insights into Probiotic Interventions for Metabolic Syndrome: Mechanisms and Evidence
Chen, L., Tian, L., Zhang, Y., Shi, Y., Yuan, W., Zou, Y. L., Zhang, Q., Chen, M., & Zeng, P. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10554-x · Cited by 4
The Effect of Probiotic Supplementation on Self-Reported Sleep Quality
Reis, D. J. (2016) · KU ScholarWorks (The University of Kansas) · Cited by 4
Lee, E. L., Sulfath, T. S., Maharajan, M. K., Shanmugham, S., Ingle, P. V., Kumar, S., Ching, S. M., Lee, Y. Y., & Veettil, S. K. (2025) · European Journal of Clinical and Experimental Medicine · doi:10.15584/ejcem.2025.1.22 · Cited by 4
The Oral, Genital and Gut Microbiome in HIV Infection
Pérez‐Matute, P., Íñiguez, M., Villanueva-Millán, M. J., & Oteo, J. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815249-2.00032-4 · Cited by 4
Musnadi, A. A., Malik, A., & Khayyira, A. S. (2021) · INDONESIAN JOURNAL OF PHARMACY · doi:10.22146/ijp.1054 · Cited by 4
“Postbiotics are considerably safer than probiotics due to the absence of immunogenicity caused by administering live bacteria that can cause bloating, bacteremia, and transfer of antibiotic resistance genes (Doron and Snydman, 2015; Shenderov, 2013).”
BackgroundPolypharmacology in Clinical Applications: Gastrointestinal Polypharmacology
Wang, Z., & Yang, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-04998-9_8 · Cited by 4
A Revision of Probiotic Safety in Children
Çongur, E. Ç., & Dalgıç, N. (2023) · Çocuk Enfeksiyon Dergisi/Journal of Pediatric Infection · doi:10.5578/ced.20239801 · Cited by 4
“Previous studies have demonstrated the effects of probiotics on cytokine secretion and dendritic cell function (37).”
A Revision of Probiotic Safety in Children
Çongur, E. Ç., & Dalgıç, N. (2023) · Çocuk Enfeksiyon Dergisi/Journal of Pediatric Infection · doi:10.5578/ced.20239814 · Cited by 4
An, M., & Lim, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-46436-x · Cited by 4
“Consumption of live bacteria is associated with concerns about side effects, such as systemic infections, including bacteremia, harmful metabolic activities stimulating the immune system, and genetic transfer 19 .”
BackgroundRisk Assessment of Isolated Lactobacill from Traditional Iranian Dairy Products
Bagheri, F., Mirdamadi, S., Mirzaei, M., & Safavi, M. (2020) · Food Science and Technology · doi:10.52547/fsct.17.104.65 · Cited by 4
Research Review on Genetic Engineering of Probiotics in Biotechnology
(2025) · Medicine and Plant Letters · doi:10.65822/j.mpl/2025.006 · Cited by 4
Calame, W., van Olderen, D., Calabretta, V., Bottari, L., Paparo, L., Bruno, C., Carucci, L., Voto, L., Coppola, S., & Budelli, A. (2022) · Applied Sciences · doi:10.3390/app12042009 · Cited by 4
“Consumption of probiotics might result in the occurrence of health issues to the consumer, such as translocation of microbes over the gut epithelium, the cross-over of antibiotic resistance genes, and sepsis [6].”
BackgroundAnwar, M. (2020) · Otago University Research Archive (University of Otago) · Cited by 5
Well-Being and Work–Life Balance: Cultural, Positive Psychology, and Practical Perspectives
Bolton, M. A., Lobben, I., Pruzinsky, T., & Stern, T. A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.046 · Cited by 3
Tafla, T., Balasubramanian, A., & Iyer, J. K. (2025) · Onco · doi:10.3390/onco5030041 · Cited by 3
“…appropriate strains of probiotics for patients considering the uniqueness of individual microbiomes, determining the appropriate dose due to heterogeneity in commercial preparations, risks of metabolic disorders, and other factors contribute to hesitancy in their use among oncologists [194,195].”
Piame, L. T., & Yako, Y. Y. (2026) · Applied Biosciences · doi:10.3390/applbiosci5010006 · Cited by 3
“The favourable safety profile of probiotics further supports their use as a complementary approach in diabetes management, as only a few studies have reported minor gastrointestinal disturbances or rare systemic infections in immunocompromised individuals [59,60].”
Sharma‐Brymer, V., Dashper, K. L., & Brymer, E. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.034 · Cited by 3
Abenavoli, L., YOSYPENKO, K., YURCHYSHENA, Y., Savytska, M., Lazarieva, O., Shvets, Y. V., Scarlata, G. G. M., Lynchak, O. V., & Falalyeyeva, T. M. (2026) · Minerva Gastroenterology · doi:10.23736/s2724-5985.25.04054-9 · Cited by 3
Dieppe, P. A., Goldingay, S., & Warber, S. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.042 · Cited by 3
The Handbook of Wellness Medicine
Snellings, J. E. (2021) · Family Medicine · doi:10.22454/fammed.2021.204951 · Cited by 3
Kaur, H., Singh, N., Mehta, A., Sharma, A., & Datta, S. (2024) · World Journal of Dentistry · doi:10.5005/jp-journals-10015-2403 · Cited by 3
The Role of Aesthetics in Wellness
Mikhail, A. A., & Ngor, A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.032 · Cited by 3
Reiprich, A., Skalden, L., Raab, A., Bolotina, N., & Lang, C. (2022) · Beneficial Microbes · doi:10.3920/bm2021.0103 · Cited by 3
Translation of Immunomodulatory Effects of Probiotics into Clinical Practice
Ryan, J. C., Narasimha, S. V., Pattison, R., Zackria, R., Ghobrial, Y., Basit, S. A., Ammar, T. A. R. A., Jayaraman, V., Stone, C. D., & Shih, D. Q. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.109864 · Cited by 3
Kawamoto, Y., Suzuki, M., Iwata, M., & Uehara, Y. (2024) · BMJ Case Reports · doi:10.1136/bcr-2024-261578 · Cited by 3
Vaghela, P., Dave, B. P., Dabhade, A., Deshmukh, R., Prajapati, B. G., Alsaidan, O. A., Patel, S., Mehta, A., Singh, A., & Dudhat, K. R. (2026) · Antonie van Leeuwenhoek · doi:10.1007/s10482-026-02254-5 · Cited by 3
“Moreover, other Lactobacillus species, including L. acidophilus , L. jenesenii , and Limosilactobacillus fermentum, have also been associated with bacteraemia (Doron and Snydman 2015).”
Probiotics: Past, Present and Future Challenges
AL-Taha, B. M., Wadi, J., & Shehabi, A. A. (2018) · The International Arabic Journal of Antimicrobial Agents · doi:10.3823/816 · Cited by 3
“Some probiotics create nutrients like provitamins, amino acids, polyamines, antioxidants, growth factors and short-chain fatty acids such as acetic acid which has antimicrobial function [2, 7].”
BackgroundInfluentialIshioka, K., Miyazaki, N., Nishiyama, K., & Suzutani, T. (2023) · Microorganisms · doi:10.3390/microorganisms11122949 · Cited by 3
“Probiotics need to be safe for humans, but there have been cases of infection in association with some LABs, and there is a debate about safety and risk [22,23].”
BackgroundProbiotic properties of Lactiplantibacillus plantarum KS2020 with GABA producing ability
Kwon, M.-J., Park, Y.-H., Kim, J.-H., Lee, J.-M., Lee, S., & Lee, S. (2025) · Food Science and Biotechnology · doi:10.1007/s10068-025-01920-0 · Cited by 3
“…resistance, causing toxic or cytotoxic effects, or leading to metabolic complications like D-lactic acidosis, especially Min-Jeong Kwon, Yun-Ho Park, and Joo-Hyeong Kim have equally contributed to this work. when consumed in high doses or by vulnerable populations (Doron and Snydman, 2015).”
Exploring the Therapeutic Landscape of Probiotics in Enteric and Respiratory Viral Infections
Malik, Y. S., Pathania, A., De, U. K., Manu, M., Panwar, H., Kaur, J., Mishra, A. K., Kumar, N., Ghosh, S., Sarkar, V. K., et al. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10683-3 · Cited by 3
“As an immunomodulator, probiotics exert both innate and adaptive immune responses through secretion of various cytokines and dendritic cell function; however, overstimulation of the immune response in some individuals can lead to inflammatory or autoimmune reactions [161].”
Non‐Lactic Acid Bacteria as Probiotics and their Functional Roles
Ramos, C. L., Esteves, E. A., de Miranda, N. M. Z., Moreno, L. G., & Schwan, R. F. (2022) · Wiley eBooks · doi:10.1002/9781119702160.ch4 · Cited by 3
Ullah, H., Daglia, M., & Khan, H. Z. (2022) · Wiley eBooks · doi:10.1002/9781119746843.ch5 · Cited by 3
Warrack, S. R., & Ziegler, M. J. (2016) · Journal of Probiotics & Health · doi:10.4172/2329-8901.1000142 · Cited by 3
Habteweld, H. A., Tsige, A. W., Ayenew, K. D., Habtewold, A. A., Asfaw, T., Yismaw, M. B., & Taye, H. B. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10780-3 · Cited by 3
“…from the activation of both the innate and adaptive immune systems in susceptible individuals; deleterious metabolic activities; horizontal gene transfer; and self-limiting gastrointestinal side effects such as nausea, abdominal cramping, flatulence, soft stools, and taste disturbance [114].”
Hidaka, Y., Kuriyama, A., Nishinaka, A., Takahashi, K., Nakaya, S., Kubota, T., Nakamura, S., Shimazawa, M., & Hara, H. (2023) · BPB Reports · doi:10.1248/bpbreports.6.2_47 · Cited by 3
Psychobiotics: Biotherapeutics for Positive Mental Health
Mörkl, S., Butler, M., Cichini, F., Cryan, J. F., & Dinan, T. G. (2020) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190931544.013.7 · Cited by 3
Das, K., Upadhyay, S., & Oli, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99988-5.00021-8 · Cited by 3
Enhancing Pathogen Resistance: The Gut Microbiota and Malaria
Moore, J. M., & Aparicio, J. C. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00097-8 · Cited by 3
Sleep and probiotics in diabetes management
Vitti-Ruela, B. V., Dokkedal‐Silva, V., Hirata, A. E., Tufik, S. B., & Andersen, M. L. (2023) · Primary care diabetes · doi:10.1016/j.pcd.2023.01.013 · Cited by 3
Adhikary, K., Ganguly, K., Ansari, M. Y., Chowdhury, S. R., Choudhury, S., Sadhu, D., De, S., Roy, N., Banerjee, P., Mahanti, B., et al. (2026) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70528 · Cited by 3
“These include individuals with compromised immune systems, critically ill patients, premature infants, and individuals with the presence of indwelling medical devices (e.g., central venous catheters) [ 288 ].”
Lee, J., Kim, J., Goo, B., & Nam, S. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s522270 · Cited by 3
“7 Nevertheless, awareness of the safety of these natural products is gradually increasing.”
Sécher, T., Cortès, M., Boisseau, C., Goudiaby, M. T. B., Pitiot, A., Parent, C., Thomas, M., & Heuzé‐Vourc'h, N. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101330 · Cited by 3
“29 While probiotics and especially Lactobacillus have proven safety when administered by the oral route, 45,46 only scarce data are available after application in the respiratory tract.”
Potential of Probiotics in the Management of Lung Cancer
Divyashri, G., Murthy, T. P. K., & Murahari, M. (2020) · Springer eBooks · doi:10.1007/978-981-15-8214-1_10 · Cited by 3
Systemic Sclerosis and Microbiota: Overview of Current Research Trends and Future Perspective
Kim, S., Chun, S. H., Park, H. J., & Lee, S. (2019) · Journal of Rheumatic Diseases · doi:10.4078/jrd.2019.26.4.235 · Cited by 3
Use of Probiotics in Swine Nutrition: A Review
Singh, S. (2024) · International Journal of Agriculture Extension and Social Development · doi:10.33545/26180723.2024.v7.i1f.242 · Cited by 3
Probiotic Cultures as Functional Foods
ROSALES-HARTSHORN, M. (2015) · Advanced in Food Technology and Nutritional Sciences - Open Journal · doi:10.17140/aftnsoj-1-121 · Cited by 3
Yeom, S., Yang, J., Yoon, K., Kim, S.-S., Cho, M.-J., Park, J.-H., Song, B., Park, J. H., Jin, Y. B., Kim, Y.-M., et al. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-10925-y · Cited by 3
“The theoretical safety concerns associated with NGPs therapy include systemic infections, metabolic and toxic disorders, transmission of virulence and antibiotic resistance genes, and immune hyperactivation in susceptible individuals [16, 17].”
Norovirus and Infection Control
Patel, P., & Araujo-Castillo, R. V. (2016) · Hospital Medicine Clinics · doi:10.1016/j.ehmc.2016.07.003 · Cited by 3
Phan, V., Hoàng, T. A. P., Trần, T. N., Hoàng, C., & Nguyễn, X. H. (2025) · Can Tho University Journal of Science · doi:10.22144/ctujos.2025.078 · Cited by 3
Salem, G. A., Mohamed, A. A.-R., Ghonimi, W. A. M., Abdallah, H. M., Rhouma, N. R., & Ali, R. I. (2022) · BMC Veterinary Research · doi:10.1186/s12917-022-03479-y · Cited by 3
“On the other hand, because probiotics have influences on both the innate and acquired immune systems, including effects on cytokine secretion and dendritic cell function [77, 78], exaggerated concerns have been raised about the potential to overly stimulate the immune response in some individuals, possibly leading to…”
BackgroundInsights into antibiotic resistomes from gut metagenome-assembled genomes of the free-range pigs
Dai, X., Liu, H., Bai, X., Li, D., Wang, T., Zhong, H., Xu, H., & Sun, J. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.02407-25 · Cited by 3
“While ARGs may facilitate the survival and future cultivation of these strains, their presence also raises concerns regarding safety and the potential transfer of resistance genes to pathogenic microbes within the host gut (47).”
Natural Health Sciences: A Comprehensive Guide
Dinç, R. (2025) · CRC Press eBooks · doi:10.1201/9781003520252 · Cited by 3
AMAZING NEARBY. EFFECTIVE AND SAFE PROTECTION AGAINST NOSOCOMIAL INFECTIONS
Opryshko, V., Prokhach, A., Prokhach, A., & Kurt-Ametova, A. S. (2021) · Neonatology surgery and perinatal medicine · doi:10.24061/2413-4260.xi.1.39.2021.10 · Cited by 3
Choi, Y. H., Kim, B. S., & Kang, S. (2023) · Food Science of Animal Resources · doi:10.5851/kosfa.2022.e62 · Cited by 3
Halas, V., Babinszky, L., & Fébel, H. (2025) · Agricultural sciences. · doi:10.5772/intechopen.1010731 · Cited by 3
Probiotics and Synbiotics: The Consumers Perspective
Bernatek, M., Grzemska, M., Piątek, J., & Sommermeyer, H. (2023) · Journal of Health Study and Medicine · doi:10.2478/jhsm-2023-0010 · Cited by 3
Probiotics: a supplement to the gluten-free diet in celiac disease.
Said, H. A., Elmoumou, L., Rherissi, B., & Kadmiri, N. E. (2025) · Gastroenterology and hepatology from bed to bench. · doi:10.22037/ghfbb.v18i3.3145 · Cited by 3
“These adverse events, although rare, highlight the importance of a rigorous assessment of the benefit-to-risk ratio before prescribing probiotics, particularly in immunocompromised patients, those with implanted medical devices, or those with central catheters (36).”
The conundrum of bacteria-specific antibiotics
Datta, S. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad130 · Cited by 3
Rezazadegan, M., Soheilipour, M., & Amani, R. (2026) · Scientific Reports · doi:10.1038/s41598-026-52347-4 · Cited by 3
“Also, it is possible that probiotics supplement in some participants, when introduced for the first time, activate mild mucosal immune responses, causing short-term GI discomfort such as bloating and changes in bowel habits, which may have caused increased stress about GI symptom exacerbation 59 .”
Medication provoked dysbiosis: emerging therapies targeting the micobiome
Abraham, C. A. (2025) · Lu Zone Ul (Laurentian University) · Cited by 3
Ryan, V. (2016) · Purdue e-Pubs (Purdue University System) · Cited by 3
Wang, Y., Tan, W., Li, X., Yang, G., Wang, Y., Liao, J., Lu, A., Zhang, G., Chen, K., Yang, L., et al. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1455735 · Cited by 2
“…the hypothesis that probiotics are generally safe for the majority of the population, some studies have identi fi ed theoretical risks, including serious infections, harmful metabolic activity, immune stress and gastrointestinal dysfunction in susceptible individuals (Doron and Snydman, 2015).”
Engaging the Five Senses: Taste, Smell, See, Listen, and Touch
Bokarius, V., & Bokarius, A. V. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108650182.037 · Cited by 2
The efficacy of probiotics, prebiotics or synbiotics in scleroderma: A systematic review
Wach, A. A., Storman, D., Więckowski, K., Wojtaszek-Główka, M., Żabicka, W., Krupka, K., Abadi, A. K., Celińska‐Löwenhoff, M., & Bała, M. M. (2025) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2025.04.004 · Cited by 2
Comparative Analysis of Vaccines and Probiotics in Fighting the Covid19
Belojević, G. (2021) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2021.34.005487 · Cited by 2
“Side Effects Transverse Myelitis, Allergic reactions, Pain and Erythema at the injection site, Fatigue and Headache Abdominal cramping, Nausea, Soft stools, Flatulence [4-6,15]”
Background
Metadata
- Authors
- Doron, S., & Snydman, D. R.
- Affiliations
- Tufts Medical Center (US)
- Corresponding author
- Doron, Shira
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-28
- Volume
- 60
- Issue
- suppl_2
- Pages
- S129-S134
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC4490230
- OpenAlex
- W2027617880
- Cited by
- 942
- References
- 91
- Citations by year
- 2026: 89 · 2025: 105 · 2024: 112 · 2023: 105 · 2022: 99 · 2021: 100 · 2020: 135 · 2019: 85 · 2018: 55 · 2017: 32 · 2016: 18 · 2015: 7
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k23at003391-03)
- National Center for Complementary and Integrative Health (K23 AT-003391, 5K23 AT003391-03)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, probiotic safety, adverse events, systemic infection, immunostimulation, gene transfer, gastrointestinal adverse effects, risk assessment
- MeSH terms
- Clinical Trials as Topic, Humans, Lactobacillus, Risk, Saccharomyces, United States, Fungemia, Sepsis, Probiotics, Gene Transfer, Horizontal, Gastrointestinal Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.